A prospective study to evaluate the microbiological efficacy of antimi
crobial treatment for urinary tract infection (UTI) was performed in 6
4 catheter-free spinal cord injured (SCI) patients who were visited mo
nthly by a public health nurse who collected urine for culture and uri
nalysis. Patients also mailed urine dip slides for weekly bacterial co
unts. UTI was defined as a culture yielding greater-than-or-equal-to 1
00,000 colonies/ml. Treatment was given to asymptomatic patients only
if pyuria (greater-than-or-equal-to 10 urinary leukocytes/high powered
microscopic field) was present. Initial treatment was for 7-14 days (
group 1). When it became apparent during the study that eradication wa
s difficult and relapse or reinfection frequently occurred within a sh
ort time after cessation of antibiotic, a second treatment course of g
reater-than-or-equal-to 28 days (group 2) was given. By the end of the
study, in which all patients were followed for a minimum of 36 days p
ost treatment, 39/42 (93%) cases in group 1 and 11/13 (85%) in group 2
who had initial eradication, had relapsed or become reinfected. The m
edian number of days and standard error for group 1 to relapse or beco
me reinfected was 16 +/- 2.5, and for group 2 it was 27 +/- 6. Develop
ment of drug resistance was documented when bacteria isolated prior to
any treatment were compared with strains isolated after greater-than-
or-equal-to 28 days of antibiotics. In this study, urine sterility was
achieved in a minority of treated UTIs and was relatively short lived
. Advisability of treating asymptomatic UTI following SCI is questiona
ble from both a medical-economic and microbiologic standpoint, particu
larly in view of the likelihood of inducing multidrug resistance with
prolonged antibiotic exposure.